Format

Send to

Choose Destination
Perspect Clin Res. 2019 Jan-Mar;10(1):1-3. doi: 10.4103/picr.PICR_196_18.

Subject expert committees: Past, present, and future.

Author information

1
Head Regulatory Affairs, Global Drug Development India, Novartis Healthcare Private Ltd., Mumbai, Maharashtra, India.
2
Chief Scientific Officer, Novartis India Limited, Mumbai, Maharashtra, India.

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center